Ritholtz Wealth Management’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$607K Sell
24,243
-95
-0.4% -$2.25K 0.01% 720
2025
Q4
$641K Sell
24,338
-384
-2% -$8.38K 0.01% 643
2025
Q3
$422K Sell
24,722
-513
-2% -$7.34K 0.01% 729
2025
Q2
$317K Sell
25,235
-35,259
-58% -$420K 0.01% 779
2025
Q1
$720K Sell
60,494
-13,972
-19% -$191K 0.02% 488
2024
Q4
$1.09M Buy
74,466
+4,297
+6% +$60.1K 0.03% 344
2024
Q3
$881K Buy
70,169
+24,136
+52% +$263K 0.03% 404
2024
Q2
$392K Sell
46,033
-34,846
-43% -$310K 0.01% 588
2024
Q1
$851K Buy
80,879
+49,190
+155% +$546K 0.03% 397
2023
Q4
$329K Buy
+31,689
New +$253K 0.01% 581
2023
Q3
Sell
-22,308
Closed -$193K 747
2023
Q2
$193K Buy
+22,308
New +$200K 0.01% 624

Other funds holding ZYME

Ritholtz Wealth Management's ZYME Position: Q1 2026 in Review

Ritholtz Wealth Management reduced its Zymeworks (ZYME) stake by 0.39% in Q1 2026, selling an estimated $2.25K and leaving 24,243 shares worth $607K. The position accounts for 0.01% of the portfolio, ranked #720.

Ritholtz Wealth Management first reported a position in ZYME in Q2 2023 and has held it in 11 quarters since. The position peaked at $1.09M in Q4 2024. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Ritholtz Wealth Management held 24,243 shares of Zymeworks worth $607K as of Q1 2026.
  • Ritholtz Wealth Management sold 95 Zymeworks shares in Q1 2026, an estimated $2.25K.
  • Zymeworks made up 0.01% of Ritholtz Wealth Management's portfolio in Q1 2026, its #720 holding.
  • Ritholtz Wealth Management first reported a position in Zymeworks in Q2 2023 and has held it in 11 quarters since.
  • Ritholtz Wealth Management's Zymeworks position peaked at $1.09M in Q4 2024.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Ritholtz Wealth Management's 13F filing for Q1 2026, filed 20 Apr 2026.